Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

$ 82.12 -2.39 (-2.83%) 11:08 PM EST
P/E:
33.66
P/B:
8.74
Market Cap:
$ 50.77B
Enterprise V:
$ 50.25B
Volume:
4.74M
Avg Vol (2M):
4.20M
Also Trade In:
Volume:
4.74M
Market Cap $:
50.77B
PE Ratio:
33.66
Avg Vol (2-Month):
4.20M
Enterprise Value $:
50.25B
PB Ratio:
8.74

Business Description

Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
Name Current Vs Industry Vs History
Cash-To-Debt 1.76
Equity-to-Asset 0.7
Debt-to-Equity 0.12
Debt-to-EBITDA 0.37
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.38
Distress
Grey
Safe
Beneish M-Score -2.36
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 62.61
9-Day RSI 62.32
14-Day RSI 61.1
6-1 Month Momentum % -28.21
12-1 Month Momentum % -33.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.03
Quick Ratio 2.17
Cash Ratio 1.19
Days Inventory 258.82
Days Sales Outstanding 42.26
Days Payable 55.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1